These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [Amantadine hydrochloride in the treatment of Parkinson's syndrome]. De la HerrĂ¡n J; Figuerido JA Rev Esp Otoneurooftalmol Neurocir; 1971; 29(167):45-9. PubMed ID: 5091472 [No Abstract] [Full Text] [Related]
6. [Results of two new drugs in Parkinson's disease: L-dopa and amantadine]. Sigwald J; Raymondeaud C; Piot C Rev Neurol (Paris); 1970 Feb; 122(2):145-8. PubMed ID: 4931718 [No Abstract] [Full Text] [Related]
7. [Drug therapy of Parkinson's disease with amantadine and levodopa]. Fieschi C; Nardini M; Casacchia M; Reitano M; Tedone ME; Ferrari P; Robotti E Sist Nerv; 1970; 22(2):126-43. PubMed ID: 5504552 [No Abstract] [Full Text] [Related]
8. [Clinical trial of the therapeutic effect of Amantadine-HCL in Parkinson's Disease]. Hacohen H; Gurtner B Schweiz Med Wochenschr; 1972 Apr; 102(16):583-6. PubMed ID: 5019377 [No Abstract] [Full Text] [Related]
9. L-dopa and amantadine hydrochloride in Parkinson's disease. Parkes JD; Zilkha KJ; Knill-Jones RP; Clements PJ; Baxter R Int Z Klin Pharmakol Ther Toxikol; 1971 Apr; 4(3):356-60. PubMed ID: 4931417 [No Abstract] [Full Text] [Related]
10. Parkinson's disease; modern treatment. Tolosa E Minn Med; 1973 Jun; 56(6):497-502. PubMed ID: 4575903 [No Abstract] [Full Text] [Related]
11. [Conservative therapy in the Parkinson syndrome]. Birkmayer W Wien Med Wochenschr; 1971 Nov; 121(46):827-9. PubMed ID: 5138823 [No Abstract] [Full Text] [Related]
12. [Combination of amantadine and levodopa in the treatment of Parkinson's disease. Indications. Results. Study of 58 cases]. Sigwald J; Raymondeaud C Nouv Presse Med; 1972 Apr; 1(18):1237-9. PubMed ID: 5025538 [No Abstract] [Full Text] [Related]
13. Amantadine HCL (Symmetrel) and its relation to Levo-Dopa in the treatment of Parkinson's disease. Schwab RS; England AC Trans Am Neurol Assoc; 1969; 94():85-90. PubMed ID: 4907453 [No Abstract] [Full Text] [Related]
15. [Dopaminergic agents, COMT inhibitors or amantadine? Proper treatment for your Parkinson patient]. Ceballos-Baumann AO MMW Fortschr Med; 2002 May; Suppl 2():37-43. PubMed ID: 12070848 [TBL] [Abstract][Full Text] [Related]
16. [Prolonged treatment of Parkinson's disease with amantadine and L-Dopa]. Fieschi C; Casacchia M; Nardini M; Reitano N Minerva Med; 1971 Oct; 62(82):4040-2. PubMed ID: 5125075 [No Abstract] [Full Text] [Related]
17. [The therapeutic association of L-dopa and amantadine. Preliminary results in a group of patients with Parkinson's disease]. Gomirato G; Perfetti C Riv Neurobiol; 1970; 16(3):247-54. PubMed ID: 5518838 [No Abstract] [Full Text] [Related]
18. [Amantadine in Parkinson's disease]. Vecchi L Clin Ter; 1971 Jun; 57(5):471-5. PubMed ID: 5113576 [No Abstract] [Full Text] [Related]